The relationship between thyroid dysfunction, cardiovascular morbidity and mortality in type 2 diabetes: The...

Area of Science:

• Endocrinology
• Cardiology
• Diabetology

Background:

• Subclinical thyroid dysfunction is common in type 2 diabetes.
• Its association with cardiovascular disease (CVD) events and mortality remains uncertain.
• Early detection and treatment strategies are debated.

Purpose of the Study:

• To investigate the risk of incident CVD and death in type 2 diabetes patients with undetected thyroid dysfunction.
• To determine if subclinical hypothyroidism is an independent predictor of adverse cardiovascular outcomes.

Main Methods:

• 1250 type 2 diabetes patients without known thyroid disease were categorized by serum free thyroxine (FT4) and thyrotropin (TSH).
• Participants were classified as euthyroid, subclinical hypothyroid, overt hypothyroid, subclinical thyrotoxic, or overt thyrotoxic.
• Incident myocardial infarction, stroke, and all-cause/cardiovascular mortality were tracked over 6.2-6.7 years.

Main Results:

• Subclinical hypothyroidism was the most frequent newly detected thyroid dysfunction (77.2%).
• Elevated TSH (>5.1 mU/L) was not associated with increased risk of myocardial infarction, stroke, or mortality.
• Subclinical hypothyroidism was associated with estimated glomerular filtration rate and systolic blood pressure.

Conclusions:

• Subclinical hypothyroidism is not independently linked to CVD events or mortality in type 2 diabetes.
• These findings challenge the routine screening and treatment of mild thyroid dysfunction in this population.
• Further research may clarify the role of thyroid function in diabetes management.